Approval · Notice of Compliance 137 · 2004
NEULASTA: Notice of Compliance 137
Issued March 12, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 137
- Date
- March 12, 2004
- Company
- Amgen Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Hematopoietic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEULASTA | 02249790 | Marketed |
Medicinal ingredients
- PEGFILGRASTIM 10 MG per ML